Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 382

Selected Filters:
14 October 2026

PrEP Power Demand Generation Toolkit

The PrEP Power demand generation toolkit is intended for use by local partners working with key populations (KP): men who have sex with men, trans and gender diverse people, sex workers, and people who use drugs. The PrEP Power project ran human-centered design (HCD) workshops with community members in Eswatini, Kenya, and Zambia. Everything in…

Demand Creation/Marketing, Research, Service Delivery

Document
10 September 2026

PrEP Quiz

The PrEP Quiz was developed to support adolescent girls and young women to explore methods that would align with their lifestyle, needs and personal preferences; and support healthcare providers to provide informed counseling based on client needs. If you are interested in learning more or adapting this tool for use in your setting, please reach…

Demand Creation/Marketing, Service Delivery

External Link
27 August 2026

Evolving Oral PrEP Guidance for Cis Women: What do we know, and what will it take?

Scientific consensus is evolving, but PrEP clinical equity remains unachieved. Recent data has challenged the “conventional wisdom” surrounding vaginal PrEP tissue concentrations, proving oral PrEP (TDF/FTC, TAF/FTC) is significantly more forgiving than historic messaging for cis women suggested. This has implications for what we understand as “time to protection” as well as “on-demand” PrEP, and…

Research, Service Delivery

Event
10 July 2026

Nigeria National HIV Prevention Plan 2026–2030

This plan, developed by Nigeria’s Federal Ministry of Health and Social Welfare and National Agency for the Control of AIDS, provides a roadmap for reversing the HIV epidemic in Nigeria.

Normative Guidance/Policies

Document
10 July 2026

Ghana National HIV Prevention Roadmap, 2026-2028

This National HIV Prevention Roadmap 2026-2028 outlines Ghana’s HIV and AIDS prevention measures which are based on the five core prevention pillars -Adolescent Girls and Young Women, Adolescent Boys and Young Men, Vulnerable Populations, Condoms, and Anti-Retroviral based Prevention.

Normative Guidance/Policies

Document
10 July 2026

Mozambique Guidelines for Combined Biomedical Prevention of HIV, STIs, and Viral Hepatitis, 2025

These clinical guidelines, developed by Mozambique’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
10 July 2026

Lesotho Addendum to HIV Prevention, Treatment, and Care Guidelines, 2026

These clinical guidelines, developed by Lesotho’s Ministry of Health in 2026, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
10 July 2026

Eswatini Pre-Exposure Prophylaxis Implementation Guidelines, 2025

These implementation guidelines, developed by Eswatini’s Ministry of Health in 2025, can be used to support delivery of PrEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
21 May 2026

Kenya Integrated Guidelines for Prevention, Treatment and Management of HIV, Sexually Transmitted Infections and Viral Hepatitis, 2026

These clinical guidelines, developed by Kenya’s Ministry of Health in 2026, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
19 May 2026

Global PrEP Tracker

Last update: April 2026 Visit data.prepwatch.org for a dynamic map-based tool to explore trends in PrEP use globally, including by country, product, and time period. Comprehensive datasets are available to download by clicking “download data” in the upper righthand corner. For any questions, contact [email protected]. Introduction to the Global PrEP Tracker

Monitoring & Evaluation, Service Delivery

External Link